semaglutide heart failure fda Novo Nordisk pulls Wegovy HF submission, will resubmit in 2025 FDA Approves Wegovy to Reduce

This eight-week window provides convenience for daily use without requiring constant refrigeration

The thinking is that if obesity is treated early, these cardiovascular-related benefits will start to occur even in the first three years, Dr

This effect is due to the fact that GLP-1RAs suppress appetite and reduce energy intake at a central nervous system level

Holding at a dose for an extra 4 weeks before escalating is a medically supported strategy when: Nausea or vomiting persists beyond 2 weeks at the current dose You are unable to eat at least 1,000 calories per day comfortably Dehydration symptoms appear (dark urine, dizziness on standing, dry mouth) You are losing weight faster than 1 to 2 pounds per week on the current dose (aggressive weight loss increases side effect risk) In the STEP trials, delayed escalation did not compromise overall weight loss outcomes at 68 weeks

Find My Treatment KEY BENEFITS Semaglutide is the active compound in Ozempic and Wegovy - delivered at an accessible monthly price